PrecivityAD2™ | Alzheimer's Disease | beta-amyloid plaques
HK$16,000.00Price
The PrecivityAD2™ testing technology developed by C2N Diagnostics embodies the philosophy of “Answers from the brain — and clues are found in the blood." It offers a unique and highly valuable approach.
This testing technology enables clear detection of beta-amyloid plaques in the brain. In the mechanisms of brain health and disease progression, beta-amyloid plaques are a critically important factor — they are also a key pathological hallmark of Alzheimer’s disease. By capturing and analyzing relevant clues in the blood, PrecivityAD2™ provides highly targeted and powerful support for the diagnosis, research, and application related to Alzheimer’s disease.
No Reviews YetShare your thoughts.
Be the first to leave a review.



























